Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference35 articles.
1. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years;Christenson;JAMA,2005
2. Expression of bcl-6 protein in normal skin and epidermal neoplasms;Kanazawa;Pathol Int,1997
3. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24-year population-based study;Smith;Gynecol Oncol,2000
4. Cancer biomarkers – current perspectives;Bhatt;Indian J Med Res,2010
5. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck;Nouri;Arch Dermatol,2004
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma;Molecular Cancer;2023-08-19
2. Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy;Pharmacological Research;2020-11
3. Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines;International Journal of Molecular Medicine;2019-05-30
4. Sequence-dependent synergistic cytotoxicity of icotinib and pemetrexed in human lung cancer cell lines in vitro and in vivo;Journal of Experimental & Clinical Cancer Research;2019-04-05
5. Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies;Oncotarget;2016-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3